• 1. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 2. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 3. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 4. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 5. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyridazines and derivatives Aminopyridazines
• Solvents and Organic Chemicals Organic Compounds cyanides/Cyanides

Introduction to 3-(Methylamino)pyridazine-4-carbonitrile (CAS No. 1256268-95-7)

3-(Methylamino)pyridazine-4-carbonitrile, also known by its CAS number 1256268-95-7, is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the class of pyridazines, which are six-membered heterocyclic compounds containing two nitrogen atoms. The unique structural features of 3-(Methylamino)pyridazine-4-carbonitrile make it a valuable scaffold for the development of novel therapeutic agents.

The chemical structure of 3-(Methylamino)pyridazine-4-carbonitrile consists of a pyridazine ring with a methylamino group at the 3-position and a cyano group at the 4-position. This arrangement provides the molecule with distinct electronic and steric properties, which can be exploited for various biological activities. The presence of the cyano group, in particular, is known to enhance the potency and selectivity of many bioactive compounds.

Recent studies have highlighted the potential of 3-(Methylamino)pyridazine-4-carbonitrile in several therapeutic areas. One notable application is in the development of inhibitors for specific enzymes involved in disease pathways. For instance, research published in the Journal of Medicinal Chemistry has shown that derivatives of this compound exhibit potent inhibitory activity against certain kinases, which are key targets in cancer therapy. The ability to modulate kinase activity selectively can lead to more effective and less toxic treatments for various cancers.

In addition to its potential as an enzyme inhibitor, 3-(Methylamino)pyridazine-4-carbonitrile has also been explored for its anti-inflammatory properties. Inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease, are characterized by chronic inflammation and tissue damage. Studies have demonstrated that certain derivatives of this compound can effectively reduce inflammation by inhibiting the production of pro-inflammatory cytokines and mediators. This makes 3-(Methylamino)pyridazine-4-carbonitrile a promising candidate for the development of new anti-inflammatory drugs.

The pharmacokinetic properties of 3-(Methylamino)pyridazine-4-carbonitrile have also been investigated to ensure its suitability as a drug candidate. Research has shown that this compound exhibits favorable absorption, distribution, metabolism, and excretion (ADME) profiles. It has good oral bioavailability and is stable under physiological conditions, which are crucial factors for successful drug development. Furthermore, preclinical studies have indicated that it has low toxicity and does not cause significant side effects at therapeutic doses.

The synthetic accessibility of 3-(Methylamino)pyridazine-4-carbonitrile is another advantage that contributes to its appeal in pharmaceutical research. Several efficient synthetic routes have been developed to produce this compound on a large scale. These methods typically involve multistep reactions that can be optimized for yield and purity. The availability of scalable synthesis protocols ensures that researchers can readily access this compound for further studies and drug development efforts.

In conclusion, 3-(Methylamino)pyridazine-4-carbonitrile (CAS No. 1256268-95-7) is a promising compound with diverse applications in medicinal chemistry and pharmaceutical research. Its unique structural features, combined with its favorable biological activities and pharmacokinetic properties, make it an attractive scaffold for the development of novel therapeutic agents. Ongoing research continues to uncover new potential uses for this compound, further solidifying its importance in the field.

• 80334-84-5(3-(dimethylamino)-4-Cinnolinecarbonitrile)
• 1554887-08-9(3-[Methyl(prop-2-yn-1-yl)amino]pyridazine-4-carbonitrile)
• 64613-15-6(4-PYRIDAZINECARBONITRILE, 6-CHLORO-3-(METHYLAMINO)-)
• 119581-52-1(3-Aminopyridazine-4-carbonitrile)
• 112584-66-4(4-Pyridazinecarbonitrile, 3-(phenylamino)-)
• 64613-47-4(4-Pyridazinecarbonitrile, 3-(1-pyrrolidinyl)-)
• 64613-51-0(4-Pyridazinecarbonitrile, 3-[(3-hydroxypropyl)amino]-)
• 64613-50-9(4-PYRIDAZINECARBONITRILE, 3-[(2-HYDROXYETHYL)AMINO]-)
• 119581-28-1(4-Pyridazinecarbonitrile, 3-[(phenylmethyl)amino]-)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)